Olympic Ophthalmics

Olympic Ophthalmics is a venture-backed startup dedicated to developing new therapies for dry eye disease. The investors, board, and management have deep expertise in medical device technology development. Its first regulatory-approved product is a neurostimulation device that increases tear production by gently stimulating the external nasal nerve.